| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.42 | 0.008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.69 | 0.01 |